All Michael Hoelscher articles
-
NewsTherapeutic vaccine for chronic hepatitis B enters first clinical trial in patients
TherVacB, a novel therapeutic vaccine for chronic hepatitis B, has entered its first clinical trial in patients. A successful phase 1a trial in healthy volunteers saw the vaccine demonstrate a favorable safety profile and trigger the desired immune responses.
-
NewsEliminating worm infections as a key strategy for HIV/AIDS prevention
Scientists who found that infection with the worm Wuchereria bancrofti increases the risk of contracting HIV have now confirmed, as part of a national program in Tanzania, that containment of this worm infection leads to a reduction in new HIV infections.
-
NewsNew dawn in the fight against TB
UNITE4TB, the largest public-private collaboration in tuberculosis drug development, announces the start of clinical trials.